Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 15 Issue: 2
Author(s): Guy A. Caldwell
Affiliation:
Export Options
About this article
Cite this article as:
Caldwell A. Guy, Meet Our Editorial Board Member, Current Neuropharmacology 2017; 15 (2) . https://dx.doi.org/10.2174/1570159X1502170104204144
DOI https://dx.doi.org/10.2174/1570159X1502170104204144 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
18
1
1
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Inflammation, Microenvironment, and the Immune System in Cancer Progression
Current Pharmaceutical Design The Polymorphisms of DNA G-Quadruplex Investigated by Docking Experiments with Telomestatin Enantiomers
Current Pharmaceutical Design Novel Concepts in the Development of Platinum Antitumor Drugs
Current Medicinal Chemistry - Anti-Cancer Agents Microglia in Alzheimer's Disease: The Good, the Bad and the Ugly
Current Alzheimer Research Nanostructured Modulators of Neuroglia
Current Pharmaceutical Design Cognitive and Psychomotor Performance During Alcohol Hangover
Current Drug Abuse Reviews Activation of Human Platelets by 2-Arachidonoylglycerol: Role of PKC in NO/cGMP Pathway Modulation
Current Neurovascular Research Enkephalinase Inhibitors: Potential Agents for the Management of Pain
Current Drug Targets Aryl/heteroaryl Substituted Celecoxib Derivatives as COX-2 Inhibitors: Synthesis, Anti-inflammatory Activity and Molecular Docking Studies
Medicinal Chemistry Thalidomide Chemotherapy-Induced Peripheral Neuropathy: Actual Status and New Perspectives with Thalidomide Analogues Derivatives
Mini-Reviews in Medicinal Chemistry A Novel Dynamic Analysis of Mental Status Linked to Biogenic Amines and Psychopathology
Current Psychiatry Reviews The Roles of Phosphodiesterase 2 in the Central Nervous and Peripheral Systems
Current Pharmaceutical Design Development and Tailoring of Hybrid Lipid Nanocarriers
Current Pharmaceutical Design Editorial [Hot Topic: The Role of Cytokines in Neurodegeneration and Psychiatric Conditions: Multiple Mechanisms of Action (Executive Editor: Shawn Hayley)]
Current Pharmaceutical Design Molecular Targeting of Aberrant Transcription Factors in Leukemia: Strategies for RUNX1/ETO
Current Drug Targets An Updated Meta-Analysis of the Efficacy and Safety of Acupuncture Treatment for Vascular Cognitive Impairment Without Dementia
Current Neurovascular Research Meet Our Editorial Board Member:
Current Vascular Pharmacology Rosiglitazone Does Not Improve Cognition or Global Function when Used as Adjunctive Therapy to AChE Inhibitors in Mild-to-Moderate Alzheimers Disease: Two Phase 3 Studies
Current Alzheimer Research Role of Mitochondrial Heat-shock Proteins and Immunophilins in Neuro Degenerative Diseases
Current Drug Targets Long-term Treatment with Olanzapine Increases the Number of Sox2 and Doublecortin Expressing Cells in the Adult Subventricular Zone
CNS & Neurological Disorders - Drug Targets